Video Experimental Relacionado
Updated: Aug 4, 2026
06:37
Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source
Published on: February 7, 2013
La talasemia por hemoglobina E beta en Sri Lanka fue detectada
A Premawardhena1, C A Fisher, N F Olivieri
1National Thalassaemia Centre, General Hospital, Kurunegala, Sri Lanka.
Lancet (London, England)
|October 26, 2005
Resumen
La talasemia por hemoglobina E beta, común en Asia, muestra diversos resultados clínicos. Muchos pacientes pueden ser manejados sin transfusiones, incluso con bajos niveles de hemoglobina, lo que sugiere nuevos enfoques rentables.
Área de la Ciencia:
- Hematología Hematología.
- Genética La genética.
- La medicina clínica es la medicina clínica.
Sus antecedentes:
- La talasemia por hemoglobina E beta es una talasemia severa prevalente en Asia.
- Existe una comprensión limitada con respecto a su historia natural, variabilidad clínica y estrategias óptimas de manejo.
Objetivo del estudio:
- Para investigar la historia natural y la diversidad clínica de la talasemia por hemoglobina E beta.
- Evaluar el manejo de la transfusión e identificar los factores que influyen en la presentación de la enfermedad.
- Explorar enfoques de gestión alternativos y rentables.
Principales métodos:
- Un estudio longitudinal de 109 pacientes de Sri Lanka con talasemia por hemoglobina E beta durante 5 años.
- Análisis de las prácticas de transfusión, incluida la interrupción en algunos pacientes.
- Identificación de los factores genéticos y ambientales que afectan el fenotipo.
Principales resultados:
- La transfusión no se administró a 25 pacientes y se suspendió en 37 sin efectos adversos.
- Los modificadores genéticos de la hemoglobina F, la exposición a la malaria y los cambios adaptativos relacionados con la edad se relacionaron con la diversidad fenotípica.
- Muchos pacientes toleraban niveles bajos de hemoglobina sin necesidad de transfusión.
Conclusiones:
- El manejo de la talasemia por hemoglobina E beta a menudo puede excluir las transfusiones, incluso con anemia significativa.
- La diversidad fenotípica está influenciada por múltiples factores genéticos y ambientales.
- Las adaptaciones específicas de la edad sugieren potencial para el desarrollo de estrategias de gestión más rentables.
Más Videos Relacionados
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Videos de Conceptos Relacionados
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:24Hemoglobin
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...